NiKang Therapeutics Announces First Patient Dosed in A Phase 1
15 November 2021
Download
SK Biopharmaceuticals enters Greater China out-licensing 6 clinical pipelines to CNS-focused biotech Ignis Therapeutics
11 November 2021
Download
Acrivon Therapeutics Closes Oversubscribed $100 Million Series B Financing to Advance its Innovative Precision Proteomics Platform and Clinical Oncology Pipeline
11 November 2021
Download
SWIXX AND ALBIREO INK PAN-CEE AGREEMENT FOR BYLVAY®
4 November 2021
Download
IO Biotech, Inc. Announces Pricing of Initial Public Offering
4 November 2021
Download
Interview with Andreas Wicki, CEO HBM Healthcare Investments
1 November 2021
Download
Pyxis Announces Pricing of Upsized Initial Public Offering
8 October 2021
Download
IO Biotech Announces Clinical Collaboration with MSD to Evaluate IO102-IO103 with KEYTRUDA® (pembrolizumab) as First-Line Treatment in Metastatic Melanoma Patients in a Phase 3 Trial
14 September 2021
Download
Hoffen auf eine Wiederholung der Impfstoff-Bonanza
6 July 2021
Download
Monte Rosa Therapeutics Announces Pricing of Initial Public Offering
24 June 2021
Download
Ambrx Announces Pricing of Initial Public Offering
18 June 2021
Download
Numab Therapeutics Completes Oversubscribed CHF 100 Million Series C Financing
20 May 2021
Download
Relief and Applied Pharma Research (APR) Sign Binding Term Sheet for Relief to Acquire All Outstanding Shares of APR
4 May 2021
Download
Werewolf Therapeutics Announces Pricing of Upsized Initial Public Offering
30 April 2021
Download
Mineralys Therapeutics Closes $40 Million Series A Funding
6 April 2021
Download
Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics
30 March 2021
Download
IPOs of Instil Bio and Connect Biopharma increase net asset value per HBM share by CHF 4.55 (+1.5%)
22 March 2021
Download
Biotech strebt in Rekordzahl an die Börse - aus der «Finanz und Wirtschaft»
16 March 2021
Download
SWIXX SIGNS CEE REGIONAL AGREEMENT WITH JAZZ PHARMACEUTICALS FOR VYXEOS® LIPOSOMAL
15 March 2021
Download
Successful debut on the stock exchange for HBM portfolio company Longboard Pharmaceuticals
15 March 2021
Download
Monte Rosa Therapeutics Announces $95 Million Series C Financing to Accelerate Next-generation Protein Degradation Platform
12 March 2021
Download
Longboard Pharmaceuticals Announces Pricing of Initial Public Offering
12 March 2021
Download
NEURELIS ANNOUNCES CLOSE OF $114 MILLION SERIES D FINANCING ROUND TO ADVANCE NEUROSCIENCE FOCUS
10 March 2021
Download
eGenesis Announces $125 Million Series C Financing
2 March 2021
Download
SWIXX SIGNS CEE REGIONAL AGREEMENT WITH SEAGEN FOR TUKYSA®
1 March 2021
Download